Alto Neuroscience, Inc. (ANRO)
NYSE·Healthcare·Biotechnology
$24.39
+0.47%
Mkt Cap $783.30M
Analyst Ratings
Buy
11
Hold
2
Sell
0
Price Target (5 analysts)
$26.33
Range $16.00 – $35.00
Implied Upside
+8.0%
Consensus $26.33 vs current $24.39
NYSE·Healthcare·Biotechnology
$24.39
+0.47%
Mkt Cap $783.30M
Buy
11
Hold
2
Sell
0
Price Target (5 analysts)
$26.33
Range $16.00 – $35.00
+8.0%
Consensus $26.33 vs current $24.39